US equities
|
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
AMD
$649.42
▲+0.00%
MRVL
$287.01
▲+0.00%
AVGO
$375.81
▲+0.00%
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
AMD
$649.42
▲+0.00%
MRVL
$287.01
▲+0.00%
AVGO
$375.81
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about David Lindsay
Recent news which mentions David Lindsay
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Nabriva Therapeutics plc Ireland
Chris Garabedian
Neuronetics Inc/
From
Business Journals